The next health policy debate begins now, and the future direction of health reform seems more uncertain than ever. Now is the time to take advantage of the detailed, forward-looking reporting that only Inside Health Policy delivers.

Sign up for 30 days of no-obligation access for all the essential news during this critical time.

Market Stabilization Deal

GOP Conservatives, White House Push For Changes To Alexander-Murray Deal

Senate health committee Chair Lamar Alexander (R-TN) and ranking Democrat Patty Murray (WA) introduced their individual market stabilization bill Thursday (Oct. 19) with 24 Republican and Democratic co-sponsors and a barrage of health industry group support, but the demands of hold-out Republicans and the White House could swing the bill over to the Finance Committee where Chair Orrin Hatch (R-UT) remains resolutely opposed to the measure.

Alexander/Murray Open To Stronger Language On Double Dipping

Latest News

The Congressional Budget Office estimates $1.4 billion in savings from House legislation to fund community health centers and several other public health programs another two years and pay for those funding extensions by shortening the grace period for paying Obamacare insurance premiums and cutting the Prevention and Public Health Fund.

In the wake of the HHS Office of Inspector General's 2013 findings that FDA failed to identify ways to evaluate whether manufacturers are complying with Risk Evaluation and Mitigation Strategies, OIG is now investigating FDA's oversight of REMS specifically for opioids.

The federal public comment period for Iowa's 1332 waiver request endsThursday (Oct. 20), but state health officials haven't received any indication from CMS on the timing of the agency's decision, according to a health department spokesperson.

Congress should make hospitals report revenue generated by 340B drug discounts and change the criteria that determines which hospitals get those discounts, according to researchers from Vanderbilt University and the University of Chicago.

Accountable care organizations in the Medicare Shared Savings Program and three ACO demonstrations collectively saved Medicare $70.6 million in 2016 after ACO bonuses are taken into account, a CMS spokesperson said.

The IRS will reject 2017 electronic tax returns filed without confirmation of whether the filers had health insurance, the agency said Wednesday (Oct. 18).

FDA approved Wednesday (Oct. 18) Kite Pharma's Yescarta (axicabtagene ciloleucel), marking the second gene therapy approved in the United States and the first for certain types of non-Hodgkin lymphoma.